Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source introductory threshold is rendered =60; the source table is preserved separately. This is not a newly verified label transcription.
Check source scope before reading a dose
GlobalRPh RX List - MAXIPIME
Product / population
Single-agent intravenous cefepime in adults. Label-mirror schedules and UCSF institutional regimens must retain their distinct context.
Renal method
Cockcroft-Gault CrCl, mL/min; steady-state assumption; separate HD schedule
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-10
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Daily post-HD timing is not the same as post-HD-only dosing
Label and institutional sources include daily dosing and post-dialysis-only schedules. Their indication, dialysis frequency, infusion, and exposure assumptions differ.
What to reconcile: Select one complete locally approved regimen; do not add a daily dose on top of a post-HD-only schedule.
Source difference identified; final patient-specific adjudication required.
GlobalRPh-hosted RX List · Single-agent intravenous cefepime in adults. Label-mirror schedules and UCSF institutional regimens must retain their distinct context.
Renal method: Cockcroft-Gault CrCl, mL/min; steady-state assumption; separate HD schedule Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-10
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Dialysis evidence: A regimen is reported in selected content
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
The mirror's intermittent-HD schedule is 1 g on day 1, then 500 mg every 24 hours, except febrile neutropenia uses 1 g every 24 hours. Administer after HD on dialysis days. Its usual IV infusion is approximately 30 minutes.
Its non-dialysis table uses Cockcroft-Gault CrCl and assumes steady-state renal function. The separately imported UCSF dialysis and extended-infusion protocols differ; do not combine elements into an unsupported hybrid schedule.
RDM58-rxlist-cefepime-a79c7e83da-C1 · Source locator: Dosage Adjustments: Table 2 and HD paragraph; IV preparation
Source-specific limits
Selected sections only; not a complete prescribing monograph or independent clinician approval.
A hosted label mirror is not independent corroboration of its underlying label. Official confirmation remains pending unless a separate official card is shown.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.